Arrhythmia management in myotonic dystrophy type 1

JAMA

Volumn 308, Issue 4, 2012, Pages 337-338

  Groh, William J ^a   Bhakta, Deepak ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; COMPARATIVE EFFECTIVENESS; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART PACING; HUMAN; INVASIVE PROCEDURE; LETTER; MYOTONIC DYSTROPHY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT RESPONSE;

EID: 84864147158     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.6807     Document Type: Letter

References (4)

1. Wahbi K, Meune C, Porcher R, et al. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. JAMA. 2012;307(12):1292-1301.
2. Bhakta D, Shen C, Kron J, Epstein AE, Pascuzzi RM, Groh WJ. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol. 2011;22(12):1369-1375.
3. Mathieu J, Allard P, Gobeil G, Girard M, De Braekeleer M, Bégin P. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology. 1997;49(6):1646-1650. (Pubitemid 28015132)
4. Merino JL, Carmona JR, Fernández-Lozano I, Peinado R, Basterra N, Sobrino JA. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. Circulation. 1998;98(6):541-546. (Pubitemid 28371252)